Synthesis and SAR of b-annulated 1,4-dihydropyridines define cardiomyogenic compounds as novel inhibitors of TGFβ signaling

J Med Chem. 2012 Nov 26;55(22):9946-57. doi: 10.1021/jm301144g. Epub 2012 Nov 6.

Abstract

A medium-throughput murine embryonic stem cell (mESC)-based high-content screening of 17000 small molecules for cardiogenesis led to the identification of a b-annulated 1,4-dihydropyridine (1,4-DHP) that inhibited transforming growth factor β (TGFβ)/Smad signaling by clearing the type II TGFβ receptor from the cell surface. Because this is an unprecedented mechanism of action, we explored the series' structure-activity relationship (SAR) based on TGFβ inhibition, and evaluated SAR aspects for cell-surface clearance of TGFβ receptor II (TGFBR2) and for biological activity in mESCs. We determined a pharmacophore and generated 1,4-DHPs with IC(50)s for TGFβ inhibition in the nanomolar range (e.g., compound 28, 170 nM). Stereochemical consequences of a chiral center at the 4-position was evaluated, revealing 10- to 15-fold more potent TGFβ inhibition for the (+)- than the (-) enantiomer. This stereopreference was not observed for the low level inhibition against Activin A signaling and was reversed for effects on calcium handling in HL-1 cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activins / antagonists & inhibitors
  • Activins / metabolism
  • Animals
  • Calcium / metabolism
  • Cell Differentiation / drug effects*
  • Cells, Cultured
  • Dihydropyridines / chemical synthesis
  • Dihydropyridines / pharmacology*
  • Embryonic Stem Cells / cytology
  • Embryonic Stem Cells / drug effects*
  • Humans
  • Mice
  • Molecular Structure
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / drug effects*
  • Protein Binding
  • Protein Serine-Threonine Kinases / metabolism
  • Quinolones / chemical synthesis
  • Quinolones / pharmacology*
  • Receptor, Transforming Growth Factor-beta Type II
  • Receptors, Transforming Growth Factor beta / metabolism
  • Signal Transduction / drug effects*
  • Small Molecule Libraries / pharmacology*
  • Stereoisomerism
  • Structure-Activity Relationship
  • Transforming Growth Factor beta / antagonists & inhibitors*
  • Transforming Growth Factor beta / metabolism

Substances

  • Dihydropyridines
  • Quinolones
  • Receptors, Transforming Growth Factor beta
  • Small Molecule Libraries
  • Transforming Growth Factor beta
  • activin A
  • ethyl 4-(4-tert-butylphenyl)-2-methyl-5-oxo-7-(n-propyl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
  • Activins
  • 1,4-dihydropyridine
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type II
  • Calcium